Expert Interview
A third look at the potential of Gepotidacin in uncomplicated urinary tract infections and the EAGLE-2 and EAGLE-3 trials of Gepotidacin compared to current standard of care, nitrofurantoin.
Ticker(s): GSKInstitution: South Texas Womens Institute
- Obstetrician-gynecologist at South Texas Womens Institute
- Currently manages 150 patients with endometriosis and treats roughly 80 patients per month with uncomplicated UTI’s
Do you want answers to these questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
